As postsecondary students' use of "study drugs" becomes more popular with increasingly reported negative effects on health and academic performance, failing prohibitionist policies to reduce consumption, and ambiguity in literature towards best practices to address this population, we present a literature review that seeks effective solutions educational institutions can apply to improve outcom...

BACKGROUND Methylphenidate is one of the classic amphetamines which can cause or exacerbate psychotic symptoms in schizophrenia patients. CASE REPORT In this paper, a young man is presented with injection of methylphenidate tablets with acute cellulitis due to this injection and the related symptoms. In the first hospitalization and after recovery from psychotic disorder due to tablet injecti...

the aim of this study was to determine melatonin effects on sleep patterns, symptoms of hyperactivity and attention deficiency in children with attention-deficit hyperactivity disorder (adhd).children with age range of 7-12 years who had a combined form of adhd were randomly divided in to 2 groups according to gender blocks. one group took melatonin (3 or 6mg) combined with methylphenidate (rit...

Background Progressive augmentation of behavioral response following repeated psychostimulant administrations is known as behavioral sensitization, and is an experimental indicator of a drug’s liability for abuse (Robinson and Berridge, 1993; Dafny and Yang, 2006). It is known that Ritalin or methylphenidate (MPD), a drug used to treat Attention-Deficit Hyperactivity Disorder (ADHD), induces se...

Methylphenidate (MPH, Ritalin), has been prescribed to treat attention deficit/hyperactivity disorder (ADHD) since its approval by the FDA over 50 years ago. Diagnoses of pediatric patients with ADHD and the administration of MPH to treat the symptoms have increased in prevalence in recent years. A 2005 study by El-Zein et al. reported statistically significant increases in cytogenetic anomalie...

Aims The prevalence of Attention Deficit Hyperactivity Disorder (ADHD) in children with Cerebral Palsy (CP) is 19%. Whilst there evidence that methylphenidate an efficacious first line therapy for patients ADHD, a lack literature describing atomoxetine use ADHD comorbid CP. Methods Here we report the case 17-year old Caucasian female and patient was referred to Child Adolescent Mental Health Se...